At Fierce Biotech, we love a big M&A deal, but valuation does not always equal the most exciting.
In this week's episode of "The Top Line," Fierce Biotech’s Annalee Armstrong and James Waldron discuss what they think are the best and smartest acquisitions in recent years.
From obesity to radiopharmaceuticals, they give you the Fierce Biotech team’s thoughts on who got the best deal.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
